Among the more concerning findings in the report is that data from more than half of European countries show high resistance ...

They then chemically synthesized the most promising peptide, called NACAP-II, and tested its efficacy and safety on ESBL-E. coli and mammalian blood cells, respectively. The testing showed that ...

They then chemically synthesized the most promising peptide, called NACAP-II, and tested its efficacy and safety on ESBL-E.

Background: Infections caused by extended-spectrum β-lactamase (ESBL)–producing gram-negative organisms are a growing concern in hospitalized patients. Traditionally, these infections can be ...